clemastine has been researched along with atropine in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
von Nieding, G; Wagner, HM | 1 |
Rinkema, LE; Silbaugh, SA; Stengel, PW | 1 |
Habersang, S; Hempel, R; Nwude, N | 1 |
Branga, P; Coelho, D; Fernandes, T; Malheiro, D; Rodrigues, J | 1 |
1 review(s) available for clemastine and atropine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for clemastine and atropine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Effects of NO2 on chronic bronchitics.
Topics: Adult; Aged; Airway Resistance; Atropine; Bronchitis; Clemastine; Humans; Metaproterenol; Middle Aged; Nitrogen Dioxide; Oxygen; Partial Pressure; Pulmonary Alveoli; Respiration | 1979 |
Pulmonary aerosol actions of LY188695 (KB2413), a new potent H1-receptor antagonist.
Topics: Aerosols; Airway Obstruction; Animals; Atropine; Benzimidazoles; Bronchial Provocation Tests; Bronchodilator Agents; Chlorpheniramine; Clemastine; Guinea Pigs; Histamine; Histamine H1 Antagonists; Injections, Intravenous; Male; Methacholine Chloride; Methacholine Compounds | 1987 |
Studies on the action and mechanism of action of oxyfedrine on isolated tracheal chains.
Topics: Acetylcholine; Adrenergic beta-Agonists; Amphetamine; Animals; Atropine; Clemastine; Dimethylamines; Dose-Response Relationship, Drug; Ephedrine; Epinephrine; Female; Guinea Pigs; Histamine; Histamine H1 Antagonists; In Vitro Techniques; Lysergic Acid Diethylamide; Male; Muscle Contraction; Norepinephrine; Phenylephrine; Propanolamines; Propiophenones; Rabbits; Rats; Reserpine; Serotonin; Species Specificity; Thiazines; Trachea; Tyramine | 1974 |
Intraoperative anaphylaxis after intravenous atropine.
Topics: Adjuvants, Anesthesia; Aged; Anaphylaxis; Anesthesia, General; Anti-Inflammatory Agents; Atropine; Blood Pressure; Cholinesterase Inhibitors; Clemastine; Elective Surgical Procedures; Heart Rate; Histamine Antagonists; Humans; Hydrocortisone; Injections, Intravenous; Intraoperative Complications; Lumbar Vertebrae; Male; Neostigmine; Norepinephrine; Ranitidine; Skin Tests; Vasoconstrictor Agents | 2007 |